NICE clinical guidelines
Issued: December 2006 (last modified: November 2014)
CG43

Obesity: Guidance on the prevention of overweight and obesity in adults and children

This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/cg43

2 Notes on the scope of the guidance

NICE guidelines are developed in accordance with a scope that defines what the guideline will and will not cover.

The scope specified that the guideline should cover adults and children aged 2 years or older and should include advice on the following aspects of overweight and obesity:

  • identification and assessment in primary and secondary care

  • clinical management in primary and secondary care

  • clinical management of morbid obesity – in sufficient detail to inform and identify key aspects of care

  • prevention in people who are currently a healthy weight, mainly outside the clinical setting, including

    • raising awareness

    • identifying children and adults who may benefit the most from participating in prevention programmes

    • maintaining energy balance

    • developing local strategies, with a focus on multifaceted interventions in:

      • the community – services and the wider environment

      • workplaces

      • schools

      • children aged 2–5

      • black and minority ethnic groups and vulnerable groups.

During the development of the guidance it was noted that the management of overweight and obesity in non-clinical settings had been omitted from the scope; this topic was also considered.

How this guideline was developed

NICE commissioned the National Collaborating Centre for Primary Care and the Health Development Agency to develop this guidance. In April 2005, the Health Development Agency merged with NICE, and the work on this guidance was continued by NICE's Centre for Public Health Excellence. The National Collaborating Centre and the Centre for Public Health Excellence established two Guidance Development Groups (see appendix A), which reviewed the evidence and developed the recommendations. An independent Guideline Review Panel oversaw the development of the guidance (see appendix B).

There is more information about how NICE clinical guidelines are developed on the NICE website, including a booklet, 'How NICE clinical guidelines are developed: an overview for stakeholders, the public and the NHS'.